---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-23-000195"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2023-11-24T23:59:59+00:00"
generated_at: "2026-06-07T21:49:19.348547+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions receives NYSE delisting notice for delayed Q3 10-Q filing

## Summary
- NYSE notified Emergent of noncompliance on Nov 16, 2023 due to late Q3 10-Q.
- Company has six months from Nov 9, 2023 to file the 10-Q and regain compliance.
- Delay stems from evaluating state deferred tax liability adjustments affecting prior periods.
- No Q3 financial results provided; company still assessing impact of adjustments.

## SEC filing metadata
- accession: 0001367644-23-000195
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2023-11-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000195/0001367644-23-000195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000195/ebs-20231116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-23-000195
- JSON: https://secwatch.observer/filing/0001367644-23-000195.json
- Plain text: https://secwatch.observer/filing/0001367644-23-000195.txt

## Key facts
- Listing & Compliance Notices
  Emergent BioSolutions Inc. received a nyse noncompliance notice notice regarding late filing (rules 802.01E).
  - Exchange: nyse
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 802.01E
  source text: November 16, 2023, the New York Stock Exchange (the “NYSE”) notified Emergent BioSolutions, Inc. (“Emergent” or the “Company”) that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”). In accordance with the NYSE Listed Company Manual, the Company has contacted the NYSE to discuss the status of its quarterly filing. On November 24, 2023, the Company issued a press release with respect to the receipt of the notice of noncompliance from
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764423000195/0001367644-23-000195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.